Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.
Saved in:
| Title: | Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. |
|---|---|
| Authors: | Strønen E; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Toebes M; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Kelderman S; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Buuren MM; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Yang W; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., van Rooij N; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Donia M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Böschen ML; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Lund-Johansen F; K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. Department of Immunology and Transfusion Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Olweus J; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no t.schumacher@nki.nl., Schumacher TN; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands. johanna.olweus@medisin.uio.no t.schumacher@nki.nl. |
| Source: | Science (New York, N.Y.) [Science] 2016 Jun 10; Vol. 352 (6291), pp. 1337-41. Date of Electronic Publication: 2016 May 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27198675 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Strønen+E%22">Strønen E</searchLink>; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Toebes+M%22">Toebes M</searchLink>; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kelderman+S%22">Kelderman S</searchLink>; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Buuren+MM%22">van Buuren MM</searchLink>; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22van+Rooij+N%22">van Rooij N</searchLink>; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Böschen+ML%22">Böschen ML</searchLink>; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lund-Johansen+F%22">Lund-Johansen F</searchLink>; K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. Department of Immunology and Transfusion Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Olweus+J%22">Olweus J</searchLink>; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway. K. G. Jebsen Centers for Cancer Immunotherapy and for Inflammation Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. johanna.olweus@medisin.uio.no t.schumacher@nki.nl.<br /><searchLink fieldCode="AU" term="%22Schumacher+TN%22">Schumacher TN</searchLink>; Division of Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands. johanna.olweus@medisin.uio.no t.schumacher@nki.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220404511%22">Science (New York, N.Y.)</searchLink> [Science] 2016 Jun 10; Vol. 352 (6291), pp. 1337-41. <i>Date of Electronic Publication: </i>2016 May 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0404511 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-9203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200368075%22">00368075 </searchLink><i>NLM ISO Abbreviation: </i>Science <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27198675 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/science.aaf2288 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1337 Titles: – TitleFull: Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Strønen E – PersonEntity: Name: NameFull: Toebes M – PersonEntity: Name: NameFull: Kelderman S – PersonEntity: Name: NameFull: van Buuren MM – PersonEntity: Name: NameFull: Yang W – PersonEntity: Name: NameFull: van Rooij N – PersonEntity: Name: NameFull: Donia M – PersonEntity: Name: NameFull: Böschen ML – PersonEntity: Name: NameFull: Lund-Johansen F – PersonEntity: Name: NameFull: Olweus J – PersonEntity: Name: NameFull: Schumacher TN IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 06 Text: 2016 Jun 10 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1095-9203 Numbering: – Type: volume Value: 352 – Type: issue Value: 6291 Titles: – TitleFull: Science (New York, N.Y.) Type: main |
| ResultId | 1 |
